The Kappa Opioid Receptor

This book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR...

Full description

Bibliographic Details
Other Authors: Liu-Chen, Lee-Yuan (Editor), Inan, Saadet (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing 2022, 2022
Edition:1st ed. 2022
Series:Handbook of Experimental Pharmacology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02003nmm a2200277 u 4500
001 EB002006082
003 EBX01000000000000001168982
005 00000000000000.0
007 cr|||||||||||||||||||||
008 211203 ||| eng
020 |a 9783030890742 
100 1 |a Liu-Chen, Lee-Yuan  |e [editor] 
245 0 0 |a The Kappa Opioid Receptor  |h Elektronische Ressource  |c edited by Lee-Yuan Liu-Chen, Saadet Inan 
250 |a 1st ed. 2022 
260 |a Cham  |b Springer International Publishing  |c 2022, 2022 
300 |a XI, 577 p. 100 illus., 30 illus. in color  |b online resource 
505 0 |a From the contents. Preface.-Part I: Molecular aspects of KOR -- Part II: Preclinical research on pharmacology of KOR agonists and antagonists in animals -- Part III: KOR agonists and antagonists in clinical use and in past and present clinical trials 
653 |a Pharmacology 
653 |a Pharmacology/Toxicology 
700 1 |a Inan, Saadet  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Handbook of Experimental Pharmacology 
856 4 0 |u https://doi.org/10.1007/978-3-030-89074-2?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a This book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials. The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com